PFE logo Pfizer +
Pfizer
+

Pfizer (PFE) Business News

Track Pfizer in real time with a live news feed covering Pfizer stock news, official press releases, company announcements, and an archive of historical Pfizer news. ...more

  • Calendar
    Years
    Get instant access
    Sign up for free
    Get instant access
    Sign up for free
    Month
    Jan
    Feb
    Mar
    Apr
    May
    Jun
    Jul
    Aug
    Sep
    Oct
    Nov
    Dec
    Date
    Su
    Mo
    Tu
    We
    Th
    Fr
    Sa
    Selected Filter
    No selection

Moderna Tumbles 7% as Cancer Vaccine Selloff Deepens; BioNTech Falls 3%, Pfizer Holds Steady

24/7 Wall Street

9:14 AM | Monday | Oct 26, 2026

news photo
Loading...

A closely tracked personalized melanoma vaccine met its main goal. Its effect on distant spread came in far smaller than an earlier study suggested in a late-stage trial.

Read full article redirect
9:14 AM | Monday | Oct 26, 2026

Moderna Tumbles 7% as Cancer Vaccine Selloff Deepens; BioNTech Falls 3%, Pfizer Holds Steady

24/7 Wall Street

A closely tracked personalized melanoma vaccine met its main goal. Its effect on distant spread came in far smaller than an earlier study suggested in a late-stage trial.

Read full article arrow
News Thumbnail
11:15 AM | Sunday | Oct 25, 2026

Buy 8 Barron's Big Better Bets (Than T-Bills) Out Of 14 'Safer' October DiviDogs

Seeking Alpha

Eight of the fourteen highest-yield 'Safer' Big BBB Dogs, including Suburban Propane, Verizon, and Realty Income, currently meet the dogcatcher ideal for buyable dividend value. Analyst 1-year targets project average net gains of 23.91% for the top ten BBB stocks, with risk/volatility 26% below the market average. Dividend safety is highlighted by positive free cash flow yields exceeding dividend yields for the 'safer' group, while eight names show negative free cash flow margins and are considered unsafe.

Read full article arrow
News Thumbnail
11:18 AM | Saturday | Oct 24, 2026

Pfizer's 25-Valent Pediatric Pneumococcal Conjugate Vaccine Candidate Shows Robust Phase 2 Data at IDWeek 2026

Business Wire

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) today announced detailed results across serotypes from a Phase 2 study (NCT06524414) for its investigational 25-valent pneumococcal conjugate vaccine candidate, PF-07872412 (25vPnC), in infants. In the study, a four-dose series of 25vPnC elicited robust immune responses against all 25 serotypes and showed safety and tolerability comparable to four doses of PREVNAR 20ยฎ (Pneumococcal 20-valent Conjugate Vaccine). These findings were shared today.

Read full article arrow
News Thumbnail
10:00 AM | Saturday | Oct 24, 2026

4 High-Yield Dividends That Could Be Next on the Chopping Block

24/7 Wall Street

A flashy dividend yield can mask serious cracks in a company's finances, and four well-known names are showing the same warning signs that preceded Whirlpool's sudden payout suspension earlier this year.

Read full article arrow
News Thumbnail
3:00 AM | Saturday | Oct 24, 2026

Pfizer's Dividend Yield Is One of the Highest in the S&P 500. Here's Why the Dividend Is Safer Than It Might Seem

The Motley Fool

Pfizer's financial results have exceeded expectations in recent quarters. The company's newer and acquired products, as well as several that could earn approval in the coming years, will help it overcome patent cliffs.

Read full article arrow
News Thumbnail
9:17 AM | Friday | Oct 23, 2026

Moderna Sinks 4% After 18% Plunge as Melanoma Vaccine Selloff Extends; Merck and Pfizer Slip

24/7 Wall Street

Full late-stage results for the personalized melanoma vaccine from Moderna (NASDAQ:MRNA | MRNA Price Prediction) and Merck (NYSE:MRK) came back positive, yet the selling hasn't stopped. Those numbers landed short of the loftiest hopes built into a long rally.

Read full article arrow
News Thumbnail
5:43 AM | Friday | Oct 23, 2026

Better Dividend Stock to Buy and Hold: Pfizer or Bristol Myers Squibb?

The Motley Fool

Pfizer's dividend yield ranks among the highest in the healthcare sector and S&P 500. Bristol Myers Squibb maintains a more comfortable payout ratio than Pfizer, though.

Read full article arrow
News Thumbnail
12:15 PM | Thursday | Oct 22, 2026

Pfizer's High Dividend Yield May Be a Warning. Here's How Merck Compares

24/7 Wall Street

Pfizer's 5.7% dividend yield towers over Merck's, yet that gap may signal something retirees cannot afford to ignore. Before you chase the bigger payout, the coverage numbers behind each dividend tell a very different story.

Read full article arrow
News Thumbnail
10:01 AM | Tuesday | Oct 20, 2026

Pfizer Inc. (PFE) Is a Trending Stock: Facts to Know Before Betting on It

Zacks Investment Research

Pfizer (PFE) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Read full article arrow
News Thumbnail
11:25 AM | Monday | Oct 19, 2026

Pfizer's Non-Oncology Performance in Q3: Driving Factors to Watch

Zacks Investment Research

Pfizer's Q3 results will shed light on its non-oncology portfolio, as demand trends, pricing pressure and vaccine sales shape performance across key therapies.

Read full article arrow
News Thumbnail